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ABSTRACT 
This study was conducted to investigate the effects of Artificial Tear Preparations (ATP) with three different ingredients 
on contrast sensitivity in patients with dry eye syndrome. Contrast sensitivity measurements were obtained before and 
5, 15, 30, 60, and 90 minutes after administering three different ATPs, containing dextran 70, hydroxypropyl 
methylcellulose (ATP-1), polyvinyl alcohol-povidone (ATP-2) and carbomer (ATP-3) to one eye of 20 patients with dry eye 
syndrome, who had been divided to three groups. Contrast sensitivity measurements were obtained at 1.5, 3, 6, 12, and 
18 spatial frequencies (cpd). Compared with the baseline measurements, ATP-1 provided a significant increase of 1.5 and 
3 cpd at the 15th minute, 12 cpd at the 60th minute, and 18 cpd at the 30th minute, ATP-2 significantly increased 
contrast sensitivity compared with the baseline at the 15th, 30th, 60th, and 90th minute measurements, recorded as 1.5, 
3, 12, and 18 cpd, and ATP-3 provided significant increases of 18 cpd at 60th and 90th minute measurements compared 
with the baseline. In conclusion, while  ATP-2 increased the majority of contrast sensitivity measurements both at early, 
mid, and late terms, the ATP-1 and ATP-3 were found to be effective on mid-term and late-term contrast sensitivity 
measurements, respectively. 
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INTRODUCTION
The International Dry Eye Workshop (DEWS) defined dry 
eye syndrome as "a multifactorial disease of the tears 
and ocular surface that results in discomfort, visual 
impairment, and tear layer instability, with a potential to 
cause damage on the ocular surface". The syndrome is 
accompanied by increased osmolarity of the tear layer 
and inflammation of the ocular surface [1]. While the 
prevalence of dry eye syndrome has been reported as 9% 
among the population aged between 40 and 65 years 
old, after the age of 65, this rate is increased up to 15% 
[2]. Irrespective of the cause, patients with dry eye 
syndrome frequently have complaints of ‘dryness,’ 
‘sensation of a foreign body,’ ‘burning’ and ‘irritated’ 
eyes, and ‘blurred vision.’ Chronic dry eye leads to 
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changes in ocular surface, consequently resulting in a 
lower visual quality and a decrease in vision-related 
quality of life [3]. Studies have demonstrated that dry 
eye syndrome may cause a decrease in contrast 
sensitivity before there is a decrease in visual acuity. 
Patients complain of blurred and insufficient vision, even 
when they have full visual acuity. This finding has been 
demonstrated by measuring contrast sensitivity in 
healthy individuals and patients with dry eye syndrome 
[4]. Artificial Tear Preparations (ATP), which are 
administered to patients with dry eyes to reduce 
symptoms as well as to relieve them, also result in an 
improvement of contrast sensitivity. The endurance time 
of ATPs vary, depending on their ingredients [5].
 
The 
differences between the endurance times of artificial 
tears cause them to be effective on contrast sensitivity at 
different spatial frequencies. A number of studies have 
reported that in addition to the relief provided for the 
patient, the use of artificial tears also increases contrast 
sensitivity [6]. The present study was designed to 
evaluate the effects of ATPs with three different 
ingredients on contrast sensitivity in patients with dry 
eye syndrome. For this purpose, contrast sensitivity 
measurements were obtained between 5 and 90 
minutes, after the administration of ATPs.  
MATERIALS and METHODS 
This study was carried out in accordance with the 
principles of the Helsinki Declaration. All patients 
provided written informed consent for their participation 
in the study. In total, 60 females with dry eye syndrome, 
whose Schirmer 2 test result was lower than 5 mm, were 
included in the study. The patients were randomly 
divided to three groups and one of their eyes was 
administered one of the three different ATPs, containing 
dextran 70, hydroxypropyl methylcellulose (ATP-1), 
polyvinyl alcohol-povidone (ATP-2) and carbomer (ATP-
3). The other eye of each patient was considered as the 
control eye. Patients, who used contact lenses, had 
undergone refractive surgery, used any kind of eye drop 
in the previous two weeks, had any additional eye 
disorder (pterygium, etc.), had cataract, and were unable 
to answer the questions, were excluded from the study. 
The visual acuity of each patient, corrected or 
uncorrected, was at the level of 10/10 in the Snellen 
chart. Patients refractions were between +0.50 and -0.50 
spherical equivalent. The Functional Acuity Contrast Test 
(FACT) (Stereo Optical) was used for spatial contrast 
sensitivity assessment at a three-meter distance and 
illumination of 25 foot-Lamberts, as normal office 
illumination or luminance of 85 cd/m
2
. To maintain test 
accuracy, the light meter (Stereo Optical) of FACT was 
used for standardization of lighting conditions. 
Characteristics of FACT and the test method have already 
been described by Onal et al. and the current research 
followed the same procedure during contrast sensitivity 
measurement of the study subjects [7]. Data were kept 
at 95% confidence interval during the statistical analyses. 
Normally distributed data were compared between 
groups by using parametric tests, while the 
corresponding non-parametric tests were used to 
compare non-normally distributed data. Friedman and 
Kruskal-Wallis tests were used to compare dependent 
and independent variables, respectively. A P Value of < 
0.05 was considered statistically significant. 
RESULTS 
In total, 60 females with dry eye syndrome were included 
in the study and mean age of the study group was 58.65 
± 5.11 years. The mean age and Schirmer 2 test scores 
were not significantly different between the three groups 
(P > 0.05) (Table 1). Table 2 shows the mean contrast 
sensitivity measurements and Standard Deviations (SD) 
of the three groups and the control group, recorded at 
the baseline and at the 5th, 15th, 30th, 60th, and 90th 
minute, at spatial frequencies of 1.5, 3, 6, 12, and 18 
spatial frequencies (cpd). 
While the measurements recorded in the control group 
were not significantly different compared to the baseline 
at neither spatial frequency, the changes in contrast 
sensitivity caused by ATP-1, ATP-2, and ATP-3 at different 
time points are shown in Table 2. ATP-1 significantly 
increased contrast sensitivity to 1.5 and 3 cpd at the 15th 
minute, to 12 cpd at the 60th minute, and to 18 cpd at 
the 30th minute, compared to baseline. ATP-2 
significantly increased contrast sensitivity to 1.5, 3, 12, 
and 18 cpd at the 15th, 30th, 60th and 90th minute 
measurements, compared to baseline. ATP-3 was found 
to significantly increase contrast sensitivity to 18 cpd at 
60th and 90th minute measurements, compared to 
baseline. Comparison of the three different ATPs 
demonstrated that ATP-2 caused an overall increase at 
15th, 30th, 60th and 90th minute measurements, while 
ATP-1 increased contrast sensitivity at 15th, 30th, and 
60th minute measurements for only certain frequencies. 
Similarly, ATP-3 increased contrast sensitivity at the 60th 
and 90th minute measurements only for certain 
frequencies. 
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Table 1: Mean Age and Schirmer Scores of Patients 
 ATP-1 (n = 20) ATP-2 (n = 20) ATP-3 (n = 20) P-value 
Age (Years ± SD) 58.16 ± 5.22 57.65 ± 7.05 59.17 ± 2.56 P > 0.05 
Schirmer 2 test (mean ± SD) 4.8 ± 0.2 mm 4.6 ± 0.4 mm 4.7 ± 0.1 mm P > 0.05 
ATP: artificial tear preparations; n: number; SD: standard deviation; mm: millimeter. 
 
Table 2: Mean Contrast Sensitivity Measurements of Patients at Baseline and at the 5th, 15th, 30th, 60th and 90th Minute with Spatial Frequencies of 
1.5, 3, 6, 12 and 18 
 ATP-1 (n = 20) ATP -2 (n = 20) ATP -3 (n = 20) Control (n = 60) 
Baseline     
1.5 sf 20.80 ± 2.931 15.10 ± 4.327 15.00 ± 2.865 19.43 ± 3.968 
3 sf 46.35 ± 5.575 38.85 ± 5.641 36.50 ± 5.063 43.10 ± 4.919 
6 sf 57.20 ± 2.966 53.95 ± 2.544 49.30 ± 4.508 53.90 ± 3.463 
12 sf 21.15 ± 3.014 24.00 ± 3.309 30.10 ± 1.774 26.65 ± 4.468 
18 sf 7.95 ± 0.826 9.70 ± 1.342 10.65 ± 1.565 9.50 ± 1.408 
5. min.     
1.5 sf 24.65 ± 3.631 15.10 ± 3.144 13.70 ± 2.922 18.23 ± 3.127 
3 sf 45.25 ± 8.503 39.60 ± 4.083 35.30 ± 5.814 42.90 ± 5.001 
6 sf 58.25 ± 2.447 54.00 ± 3.179 44.30 ± 6.997 52.70 ± 4.244 
12 sf 21.70 ± 1.867 26.10 ± 4.876 28.60 ± 1.957 28.57 ± 3.610 
18 sf 8.45 ± 0.510 10.70 ± 2.849 9.50 ± 1.433 10.50 ± 2.004 
15. min.     
1.5 sf 33.20 ± 4.225* 23.60 ± 4.795* 14.90 ± 3.007 20.00 ± 3.701 
3 sf 61.90 ± 2.553* 53.90 ± 8.117* 36.60 ± 5.951 43.00 ± 4.207 
6 sf 60.60 ± 0.940 62.80 ± 3.861 46.80 ± 6.437 54.00 ± 4.419 
12 sf 23.00 ± 1.717 34.65 ± 1.814* 29.90 ± 2.713 26.75 ± 3.564 
18 sf 11.25 ± 2.633 15.90 ± 3.810* 11.40 ± 2.521 10.60 ± 1.440 
30 min.     
1.5 sf 26.20 ± 1.399 21.80 ± 4.584* 15.60 ± 3.218 19.97 ± 4.636 
3 sf 48.65 ± 3.717 57.30 ± 5.814* 36.50 ± 5.463 42.80 ± 4.153 
6 sf 55.60 ± 3.119 59.05 ± 3.410 47.70 ± 5.814 55.20 ± 3.019 
12 sf 23.10 ± 3.754 35.85 ± 3.133* 31.10 ± 2.864 29.40 ± 3.441 
18 sf 17.80 ± 4.299* 17.30 ± 3.063* 11.35 ± 2.498 11.60 ± 0.807 
60.min.     
1.5 sf 23.20 ± 5.167 24.20 ± 3.302* 20.40 ± 4.185 20.03 ± 2.718 
3 sf 45.75 ± 11.097 55.10 ± 4.128* 46.75 ± 5.893 40.70 ± 1.598 
6 sf 59.30 ± 4.079 59.10 ± 5.600 54.40 ± 4.967 53.20 ± 3.277 
12 sf 35.75 ± 7.786* 31.90 ± 2.713* 35.30 ± 2.536 29.30 ± 3.946 
18 sf 12.40 ± 1.273 15.00 ± 1.026* 15.20 ± 1.642* 11.60 ± 1.509 
90.min.     
1.5 sf 24.65 ± 7.322 19.80 ± 2.238* 19.30 ± 3.686 20.00 ± 3.719 
3 sf 56.00 ± 0.973 54.30 ± 5.667* 45.50 ± 6.894 41.30 ± 3.010 
6 sf 62.35 ± 2.159 57.30 ± 4.601 53.20 ± 5.406 53.30 ± 1.942 
12 sf 26.80 ± 1.989 32.70 ± 5.401* 33.10 ± 1.021 28.35 ± 3.763 
18 sf 10.10 ± 1.071 15.40 ± 1.957* 14.00 ± 1.717* 11.90 ± 1.189 
ATP: Artificial Tear Preparations; SD: Standard Deviation; min: Minute; sf: Spatial Frequency 
*: P < 0.05 
Data in table are presented as mean ± SD. 
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DISCUSSION 
The present study investigated the effects of three 
different ATPs on contrast sensitivity in patients with dry 
eye syndrome. These three different preparations were 
compared with each other, as well as the control eyes of 
the same patient, to which no tear drop had been 
administered. Measurements were obtained between 5 
and 90 minutes after administering ATPs, with the aim of 
investigating the short-term effects of ATPs on contrast 
sensitivity. Previous studies have suggested that ATPs 
may negatively affect contrast sensitivity immediately 
after administration, yet this may improve after a certain 
time period [6, 8-10]. Objective findings obtained in the 
present study demonstrated that artificial tears had 
positive effects on contrast sensitivity in the short-term. 
The improvement in the 3 cpd range of contrast 
sensitivity may be limited change of visual performance.  
High spatial frequencies closely influence reading 
capabilities and finer resolution tasks [11]. However, low 
to middle spatial frequencies could improve facial 
recognition capability [12]. At 3 cpd, which is the medium 
spatial frequency corresponding to the highest contrast 
sensitivity in healthy eyes, ATP-2 provided significant 
increases in the measurements obtained at the 15th, 
30th, 60th, and 90th minute. ATP-1 contains dextran 70 
and hydroxypropyl methylcellulose, and has moderate 
viscosity, therefore, it causes a marked improvement in 
contrast sensitivity at certain spatial frequencies at the 
15th, 30th and 60th minute. ATP-2, which contains 
polyvinylpyrrolidone and has a higher viscosity, improved 
contrast sensitivity at all spatial frequencies in the 
measurements obtained at the 15th, 30th, 60th, and 
90th minute. 
ATP-3, which contains carbomer, has a higher density 
and therefore decreases contrast sensitivity, five minutes 
after use; however, contrast sensitivity returned to 
baseline levels at the 15th and 30th minute 
measurements and was found to be increased at the 
measurements obtained at the 60th and 90th minute. 
Carbomers are synthetic polymers that are found as 
active ingredients in several topical agents commonly 
used by patients with dry eye syndrome. They are 
hydrophilic polymer-based substances with a high 
molecular weight, and they have similar pH and 
osmolarity as natural tears [13].
 
These characteristics 
allow them to form a long-lasting, transparent, 
lubricated, and wet film layer on the eye surface. As 
carbomer has a high molecular weight, it cannot be 
absorbed through the eyes or be accumulated in eye 
tissue [14]. In a multi-center, randomized, placebo-
controlled study, it was demonstrated that carbomer was 
safe and more effective than the placebo, in terms of 
improving subjective and objective symptoms of 
moderate to advanced dry eye syndrome [15]. In a 
prospective study conducted by Xiao Q et al. to compare 
the clinical efficacy of artificial tears containing 0.4% 
carbomer and 1% carboxymethyl cellulose in patients 
with dry eye syndrome, carbomer gel was found to 
remain on the cornea for a longer period and be more 
effective than carboxymethyl cellulose [16]. In another 
randomized double-blind study conducted by Johnson et 
al.,
 
the efficacy of 3% carbomer and 0.18% sodium 
hyaluronate on dry eyes was compared and both agents 
were found to decrease symptom severity, while they did 
not have long-term effects on Tear Breakup Time (TBUT) 
[17]. Therefore, artificial tear drops increase optic quality 
by forming a more lubricated and smoother layer on the 
cornea surface and they eventually improve contrast 
sensitivity. The duration of contact with cornea and 
endurance time of ATPs vary according to their 
ingredients, and these factors determine which ATP 
improves contrast sensitivity at a given spatial frequency 
and time interval. Particularly, in patients with dry eye 
syndrome that causes disruption of ocular surface, 
recovery of the ocular surface gains significance for 
increasing contrast sensitivity [18]. Patients with dry eye 
syndrome complain of decreased visual quality even if 
they have full visual acuity. This is because contrast 
sensitivity is already lost before visual acuity starts to 
decrease. ATPs used at this stage increase visual quality 
of the patients, while providing relief of symptoms, such 
as burning, stinging, soreness, irritation and gritty, and 
itchy sensations experienced by the patients [19]. Having 
a cross sectional study design, measurement of only 
contrast senility, as one of vision quality measures, and 
lack of evaluation of ATPs long term effects on quality of 
vision could be considered as limitations of the current 
study.  Moreover, contrast sensitivity, as a 
psychophysical test, is not constant. Therefore, for better 
evaluation of shorter term effects of ATPs on dry eyes, 
more constant measures of visual optics, such as 
dynamic wavefront aberrometry, are recommended [20].  
CONCLUSION  
ATPs provide both symptom relief in patients with dry 
eye syndrome, and increase visual quality by increasing 
contrast sensitivity, depending on their ingredient 
content. Future studies with larger sample sizes and 
additional measures of tear residence time and dynamic 
aberrometry may be helpful for characterization of 
better visual benefits of artificial tears in the short-term. 
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